← Back to search

ABBVIE INC.

ABBV · NEW YORK STOCK EXCHANGE INC.

Pharmaceutical Preparation Manufacturing

AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. The Company strives to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio.

ESG Scores

Overall ESG
5.4
Environmental
7.7
Social
4.4
Governance
4.5

Public ESG Grades

Overall: BBB (High)
E: AS: BBG: BB

Gender Diversity

Female Directors0.2727%
Female Executives0.15853658536585366%
Women in Workforce0.55%
CEO GenderMale

Market Data

Price$203.71-4.67 (-2.24%)
Market Cap$364.98B
P/E Ratio86.37
EPS$—
52W High$244.81
52W Low$168.54
Beta0.30